
Technology used to produce the Covid vaccine has been shown to cut the risk of cancer tumours returning, new research has shown.
Pharmaceutical firms Moderna and Merck are working on personalised cancer vaccine, designed to prime the immune system so the body can generate a response based on a person’s specific type of cancer tumour.